title: Does nanocrystalline silver have a transferable effect?
abstract: This study examined the mechanism of nanocrystalline silver antiinflammatory activity, and tested nanocrystalline silver for systemic antiinflammatory effects. Secondary ion mass spectroscopy of skin treated directly with nanocrystalline silver for 24 hours showed that at skin surfaces there were significant deposits at weights corresponding to Ag, AgO, AgCl, AgNO(3), Ag(2)O, and silver clusters Ag(2-6), but silver penetration was minimal. To test for translocation of the effect, a porcine contact dermatitis model in which wounds were induced on one side of the back and then treated with nanocrystalline silver on the opposite side of the back was used. Visual and histological data showed improvement relative to animals treated with saline only. Significantly increased induction of apoptosis in the inflammatory cells present in the dermis was observed with remote nanocrystalline silver treatments. In addition, immunohistochemical analysis showed decreased levels of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-8, and increased levels of antiinflammatory cytokine interleukin-4, epidermal growth factor, keratinocyte growth factor, and keratinocyte growth factor-2. Thus, the antiinflammatory effects of nanocrystalline silver appear to be induced by interactions with cells in the top layers of the skin, which then release biological signals resulting in widespread antiinflammatory activity.
authors.affiliation: Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada.
authors.forename: Patricia L
authors.initials: PL
authors.lastname: Nadworny
authors.forename: Breanne K
authors.initials: BK
authors.lastname: Landry
authors.forename: JianFei
authors.initials: J
authors.lastname: Wang
authors.forename: Edward E
authors.initials: EE
authors.lastname: Tredget
authors.forename: Robert E
authors.initials: RE
authors.lastname: Burrell
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000378:metabolism; D051526:Fibroblast Growth Factor 10 / Q000378:metabolism; D051523:Fibroblast Growth Factor 7 / Q000378:metabolism; D007150:Immunohistochemistry; D013058:Mass Spectrometry; D023421:Models, Animal; D053758:Nanoparticles; D012834:Silver / Q000494:pharmacology*; D013552:Swine; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000893:Anti-Inflammatory Agents; D016207:Cytokines; D051526:Fibroblast Growth Factor 10; D051523:Fibroblast Growth Factor 7; D012834:Silver; D004815:Epidermal Growth Factor